Trial Profile
Clinical Trials Insight: 700030707
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 21 Feb 2008
Price :
$35
*
At a glance
- Drugs Rifalazil (Primary) ; Azithromycin
- Indications Chlamydial infections
- Focus Therapeutic Use
- Sponsors ActivBiotics
- 21 Feb 2008 New trial record.